Dexcom’s first-gen CGM sensor developed with Verily won’t see light of day, at least in the U.S.
San Diego-based Dexcom said at the annual J.P. Morgan Healthcare Conference in San Francisco that it's first-gen product co-developed by Alphabet's Verily may never get launched in the U.S.